GOT1 (glutamic-oxaloacetic transaminase 1) is a cytosolic aminotransferase that catalyzes the reversible transamination of L-aspartate and α-ketoglutarate to oxaloacetate and L-glutamate. The enzyme plays critical roles in amino acid metabolism, serving as an important regulator of glutamate levels and acting as a glutamate scavenger for neuroprotection. GOT1 participates in hepatic glucose synthesis during development through its aspartate aminotransferase activity and contributes to adipocyte glyceroneogenesis. Additionally, GOT1 can utilize L-cysteine as a substrate to regulate mercaptopyruvate levels, which serves as an important source of hydrogen sulfide through the action of 3-mercaptopyruvate sulfurtransferase, with hydrogen sulfide functioning as a synaptic modulator and neuroprotectant. While the provided abstracts discuss various aspects of pancreatic cancer metabolism, autophagy regulation, and metabolic pathways, none specifically characterize GOT1's function or clinical significance. The enzyme's role in cancer metabolism, particularly in the context of amino acid utilization and metabolic reprogramming that characterizes pancreatic ductal adenocarcinoma, remains to be definitively established based on the available literature provided.